NO20040857L - Ny oral forlenget frigivelses doseringsform. - Google Patents

Ny oral forlenget frigivelses doseringsform.

Info

Publication number: NO20040857L
Authority: NO; Norway
Prior art keywords: dosage form; release dosage; prolonged release; new oral; oral prolonged
Prior art date: 2001-08-29

Application number

NO20040857A

Other languages

English (en)

Inventor

Karin Ellstrom

Ulf Kjellberg

Hakan Nyquist

Anders Ringberg

Annika Schweighofer

Original Assignee

Astrazeneca Ab Global Ip

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-29

Filing date

2004-02-26

Publication date

2004-04-19

2004-02-26 Application filed by Astrazeneca Ab Global Ip filed Critical Astrazeneca Ab Global Ip

2004-04-19 Publication of NO20040857L publication Critical patent/NO20040857L/no

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates

NO20040857A 2001-08-29 2004-02-26 Ny oral forlenget frigivelses doseringsform. NO20040857L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0102887A SE0102887D0 (sv)	2001-08-29	2001-08-29	New formulation
PCT/SE2002/001541 WO2003017983A1 (en)	2001-08-29	2002-08-28	A new extended release oral dosage form

Publications (1)

Publication Number	Publication Date
NO20040857L true NO20040857L (no)	2004-04-19

Family

ID=20285178

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20040857A NO20040857L (no)	2001-08-29	2004-02-26	Ny oral forlenget frigivelses doseringsform.

Country Status (14)

Country	Link
US (1)	US20040197404A1 (no)
EP (1)	EP1423099A1 (no)
JP (1)	JP2005504052A (no)
KR (1)	KR20040032977A (no)
CN (1)	CN1549705A (no)
BR (1)	BR0212167A (no)
CA (1)	CA2457341A1 (no)
HU (1)	HUP0401599A3 (no)
IL (1)	IL160371A0 (no)
MX (1)	MXPA04001805A (no)
NO (1)	NO20040857L (no)
SE (1)	SE0102887D0 (no)
WO (1)	WO2003017983A1 (no)
ZA (1)	ZA200401547B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2755273T3 (es) *	2004-12-03	2020-04-22	Merck Sharp & Dohme	Formulación farmacéutica de inhibidores de la carboxamida VIH integrasa que contienen una composición de control de la velocidad de liberación
EP1946780B1 (en)	2005-11-11	2012-01-11	Asahi Kasei Chemicals Corporation	Controlled release solid preparation
GB0616794D0 (en) *	2006-08-24	2006-10-04	Arrow Int Ltd	Solid dosage form
GB0618879D0 (en)	2006-09-26	2006-11-01	Zysis Ltd	Pharmaceutical compositions
EP2341912B1 (en)	2008-09-05	2014-01-22	Supernus Pharmaceuticals, Inc.	Method of treatment of attention deficit/hyperactivity disorder (adhd)
EP2780016A4 (en)	2011-11-07	2015-08-05	Diakron Pharmaceuticals Inc	EXTENDED RELEASE FORMULATION OF DIRECT THROMBIN INHIBITOR
EP4233915A3 (en) *	2012-02-08	2023-09-20	Supernus Pharmaceuticals, Inc.	Modified release formulations of viloxazine
US10071058B2 (en) *	2012-03-07	2018-09-11	Santarus, Inc.	Controlled-release solid dosage forms of mesalamine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE457505B (sv) *	1984-01-10	1989-01-09	Lejus Medical Ab	Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
US4837032A (en) *	1986-02-04	1989-06-06	Farval Ag	Theophylline sustained release tablet
GB8624213D0 (en) *	1986-10-09	1986-11-12	Sandoz Canada Inc	Sustained release pharmaceutical compositions
PE57198A1 (es) *	1996-03-25	1998-10-10	American Home Prod	Formula de liberacion prolongada
SE510305C2 (sv) *	1997-05-30	1999-05-10	Astra Ab	Nytt salt
MY120279A (en) *	2000-05-26	2005-09-30	Pharmacia Corp	Use of a celecoxib composition for fast pain relief

2001
- 2001-08-29 SE SE0102887A patent/SE0102887D0/xx unknown
2002
- 2002-08-28 JP JP2003522503A patent/JP2005504052A/ja active Pending
- 2002-08-28 KR KR10-2004-7002920A patent/KR20040032977A/ko not_active Application Discontinuation
- 2002-08-28 CA CA002457341A patent/CA2457341A1/en not_active Abandoned
- 2002-08-28 MX MXPA04001805A patent/MXPA04001805A/es unknown
- 2002-08-28 EP EP02763155A patent/EP1423099A1/en not_active Withdrawn
- 2002-08-28 WO PCT/SE2002/001541 patent/WO2003017983A1/en not_active Application Discontinuation
- 2002-08-28 IL IL16037102A patent/IL160371A0/xx unknown
- 2002-08-28 BR BR0212167-0A patent/BR0212167A/pt not_active IP Right Cessation
- 2002-08-28 CN CNA028168712A patent/CN1549705A/zh active Pending
- 2002-08-28 HU HU0401599A patent/HUP0401599A3/hu unknown
- 2002-08-28 US US10/488,125 patent/US20040197404A1/en not_active Abandoned
2004
- 2004-02-25 ZA ZA200401547A patent/ZA200401547B/en unknown
- 2004-02-26 NO NO20040857A patent/NO20040857L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
MXPA04001805A (es)	2004-07-08
WO2003017983A1 (en)	2003-03-06
KR20040032977A (ko)	2004-04-17
US20040197404A1 (en)	2004-10-07
EP1423099A1 (en)	2004-06-02
HUP0401599A3 (en)	2007-03-28
IL160371A0 (en)	2004-07-25
HUP0401599A2 (hu)	2004-11-29
ZA200401547B (en)	2004-11-17
BR0212167A (pt)	2004-07-20
CA2457341A1 (en)	2003-03-06
CN1549705A (zh)	2004-11-24
SE0102887D0 (sv)	2001-08-29
JP2005504052A (ja)	2005-02-10

Legal Events

Date	Code	Title	Description
2007-03-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
TR200003788A3 (tr)	2001-07-23	Yavas salimli oral dozaj bilesim.
NO20023728D0 (no)	2002-08-07	Manipuleringsresistente, orale opioidagonistformuleringer
ZA200207755B (en)	2004-03-26	Simethicone solid oral dosage form.
EE200000497A (et)	2001-12-17	Kiiresti lahustuv peroraalne ravimvorm
NO20025450L (no)	2002-11-14	Ny farmasöytisk sammensetning
NO20030713D0 (no)	2003-02-14	Oral faststoffdose vaksine
IS6686A (is)	2003-01-16	Hýdrógel-drifið lyfjaskömmtunarform
NL1017075A1 (nl)	2001-07-11	Preparaat.
ITTO20000779A0 (it)	2000-08-04	Composizioni farmaceutiche.
DK1199054T3 (da)	2004-09-27	Væskefrakturhånddel
NO20033556L (no)	2003-10-09	Farmasöytiske formuleringer
ATE289796T1 (de)	2005-03-15	Orale zusammensetzung
NL1018939A1 (nl)	2002-09-13	Maandverband.
DK1381367T3 (da)	2012-04-10	Oral aripiprazolopløsning
NO20040125L (no)	2004-01-12	Enterale formuleringer
EE200300416A (et)	2003-12-15	Ravimvorm
MXPA03001425A (es)	2003-06-06	Compuestos farmaceuticos.
DE60214455D1 (de)	2006-10-19	Dentale Reibahle
DE10196204T1 (de)	2003-04-24	Orale Vorrichtungen
DE50209245D1 (de)	2007-02-22	Neuroprotektives medikament
DE60326998D1 (de)	2009-05-14	Orale zubereitung
NO20040857L (no)	2004-04-19	Ny oral forlenget frigivelses doseringsform.
NO20040966D0 (no)	2004-03-05	Orale vaksiner.
MXPA03001857A (es)	2003-06-04	Composicones medicinales.
NO20040866L (no)	2004-04-19	Ny oral forlenget frigivelses doseringsform